Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathologic study

Neurology

Volumn 48, Issue 1, 1997, Pages 119-125

  Litvan, Irene ^a   Agid, Y ^b   Goetz, C ^c   Jankovic, J ^d   Wenning, G K ^e   Brandel, J P ^b   Lai, E C ^d   Verny, M ^b   Ray Chaudhuri, K ^f   McKee, A ^g   Jellinger, K ^h   Pearce, R K B ^e   Bartko, J J ⁱ  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c RUSH MEDICAL COLLEGE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e Institute of Neurology   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

ⁱ NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN CORTEX; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; INTESTINE LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NIEMANN PICK DISEASE; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY;

EID: 0031026460     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.1.119     Document Type: Article

References (73)

1. Rebeiz JJ, Kolodny EH, Richardson EP. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968;18: 20-33.
2. Riley DE, Lang AE, Lewis A, et al. Cortical-basal ganglionic degeneration. Neurology 1990;40:1203-1212.
3. Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration: a clinical study of 36 cases. Brain 1994;117: 1183-1196.
4. Lippa CF, Smith TW, Fontneau N. Corticonigral degeneration with neuronal achromasia: a clinicopathologic study of two cases. J Neurol Sci 1990;98:301-310.
5. Lippa CF, Cohen R, Smith TW, Drachman DA. Primary progressive aphasia with focal neuronal achromasia. Neurology 1991;41:882-886.
6. Pillon B, Blin J, Vidailhet M, et al. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 1995;45:1477-1483.
7. Chen R, Ashby P, Lang AE. Stimulus-sensitive myoclonus in akinetic-rigid syndromes. Brain 1992;115:1875-1888.
8. Thompson PD, Day BL, Rothwell JC, Brown P, Britton TC, Marsden CD. The myoclonus in corticobasal degeneration: evidence for two forms of cortical reflex myoclonus. Brain 1994; 117:1197-1207.
9. Riley DE, Lang AE. Cortical-basal ganglionic degeneration. In: Stern MB, Koller WC, eds. Parkinsonian syndromes. New York: Marcel Dekker, 1993:379-392.
10. Lang AE, Bergeron C, Pollanen MS, Ashby P. Parietal Pick's disease mimicking cortical-basal ganglionic degeneration. Neurology 1994;44:1436-1440.
11. Jendroska K, Rossor M, Mathias C, Daniel S. Morphological overlap between corticobasal degeneration and Pick's disease: a clinicopathological report. Mov Disord 1995;10:111-114.
12. Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 1996;46:922-930.
13. Gibb WR, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989;112:1171-1192.
14. Gibb WR, Luthert PJ, Marsden CD. Clinical and pathological features of corticobasal degeneration. Adv Neurol 1990;53:51-54.
15. Feany MB, Mattiace LA, Dickson DW. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol 1996;55: 53-67.
16. Delacourte A, Robitaille Y, Sergeant N, et al. Specific pathological tau protein variants characterize Pick's disease. J Neuropathol Exp Neurol 1996;55:159-168.
17. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44: 2015-2019.
18. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990;237:197-204.
19. Bartko JJ, Carpenter WT. On the methods and theory of reliability. J Nerv Ment Dis 1976;163:307-317.
20. Gross ST. The kappa coefficient of agreement for multiple observers when the number of subjects is small. Biometrics 1986;42:883-893.
21. Cyr L, Francis K. Measures of clinical agreement for nominal and categorical data: the kappa coefficient. Comput Biol Med 1992;22:239-246.
22. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
23. Galèn S, Gambino SR. Beyond normality: the predictive value and efficiency of medical diagnoses. New York: John Wiley & Sons, 1975.
24. Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley & Sons, 1981.
25. SAS Institute Inc. SAS Procedures Guide. Cary, NC: SAS Institute, Inc., 1990.
26. Ball JA, Lantos PL, Jackson M, Marsden CD, Scadding JW, Rossor MN. Alien hand sign in association with Alzheimer's histopathology. J Neurol Neurosurg Psychiatry 1993;56:1020-1023.
27. LeWitt P, Friedman J, Nutt J, Korczyn A, Brogna C, Truong D. Progressive rigidity with apraxia: the variety of clinical and pathological features [abstract]. Neurology 1989;39(suppl 1):140.
28. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 46-1993. A 75-year-old man with right-sided rigidity, dysarthria, and abnormal gait. N Engl J Med 1993;329:1560-1567.
29. Cambier J, Mason M, Dairou R, Henin D. Etude anatomoclinique d'une forme pariétale de maladie de Pick. Rev Neurol (Paris) 1981;137:22-28.
30. Giladi N, Fahn S. Hemiparkinsonism-hemiatrophy syndrome may mimic early-stage cortical-basal ganglionic degeneration. Mov Disord 1992;7:384-385.
31. Gouider-Khouja N, Vidailhet MJ, Bonnet AN, Pichon J, Agid Y. "Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical study. Mov Disord 1995;19:288-294.
32. Eberhard J, Lopes MBS, Trugman JM, Brashear HR. Alzheimer's disease in a case of corticobasal degeneration with severe dementia [letter]. J Neurol Neurosurg Psychiatry 1996; 60:109-110.
33. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathological criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97-105.
34. Mori H, Nishimura M, Namba Y, Oda M. Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Acta Neuropathol (Berl) 1994;88:113-121.
35. Feany MB, Ksiezak-Reding H, Liu WK, Vincent I, Yen SH, Dickson DW. Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol (Berl) 1995; 90:37-43.
36. Buée-Scherrer V, Hof PR, Buée L, et al. Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol 1996 (in press).
37. Feany MB, Dickson DW. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 1995; 146:1388-1396.
38. Halliday GM, Davies L, McRitchie DA, Cartwright H, Pamphlett R, Morris JG. Ubiquitin-positive achromatic neurons in corticobasal degeneration. Acta Neuropathol (Berl) 1995;90: 68-75.
39. Leiguarda R, Lees AJ, Merello M, Starkstein S, Marsden CD. The nature of apraxia in corticobasal degeneration. J Neurol Neurosurg Psychiatry 1994;57:455-459.
40. Gimenez-Roldan S, Mateo D, Benito C, Grandas F, Perez-Gilabert Y. Progressive supranuclear palsy and corticobasal ganglionic degeneration: differentiation by clinical features and neuroimaging techniques. J Neural Transm Suppl 1994; 42:79-90.
41. Rey GJ, Tomer R, Levin BE, Sanchez-Ramos J, Bowen B, Bruce JH. Psychiatric symptoms, atypical dementia, and left visual field inattention in corticobasal ganglionic degeneration. Mov Disord 1995;10:106-110.
42. Frisoni GB, Pizzolato G, Bianchetti A, Chierichetti F, Trabucchi M. Corticobasal degeneration: neuropsychological assessment and dopamine D2 receptor SPECT analysis. Eur Neurol 1995;35:50-54.
43. Quinn N. Parkinsonism-recognition and differential diagnosis. BMJ 1995;310:447-452.
44. Wenning G, Ben-Shlomo Y, Magalhaes M, Daniel S, Quinn N. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain 1994;117:835-845.
45. Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:160-166.
46. Massman PJ, Kreiter KT, Jankovic J, Doody RS. Neuropsychological distinctions between cortico-basal ganglionic degeneration (CBGD) and Alzheimer's disease with extrapyramidal signs (AD+EPS) [abstract]. Neurology 1994;44(suppl 2): A194-A195.
47. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival. J Neurol Neurosurg Psychiatry 1996;61:615-620.
48. Maher ER, Lees AJ. The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1986;36:1005-1008.
49. Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology 1988;38:1031-1034.
50. Paulus W, Selim M. Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles. Acta Neuropathol (Berl) 1990;81:89-94.
51. Lennox G, Jackson M, Lowe J. Corticobasal degeneration manifesting as a frontal lobe dementia. Ann Neurol 1994;36: 273-274.
52. Oda T, Ikeda K, Akamatus W, et al. An autopsy case of corticobasal degeneration clinically misdiagnosed as Pick's disease. Seishin Shinkeigaku Zasshi 1995;97:757-769.
53. Kertesz A, Hudson L, Mackenzie IR, Munoz DG. The pathology and nosology of primary progressive aphasia. Neurology 1994;44:2065-2072.
54. Case records of the Massachusetts General Hospital. Case 38-1985. N Engl J Med 1985;313:739-748.
55. Watts RL, Mirra SS, Young RR, Burger PC, Villier JA, Heyman A. Corticobasal ganglionic degeneration (CBGD) with neuronal achromasia: clinical-pathological study of two cases [abstract]. Neurology 1989;39(suppl 1):140.
56. Gross CR, Shinar D, Mohr JP, et al. Interobserver agreement in the diagnosis of stroke types. Arch Neurol 1986;43:893-898.
57. Lindley RI, Warlow CP, Wardlaw JM, Dennis MS, Slattery J, Sandercock PAG. Interobserver reliability of a clinical classification of acute cerebral infarction. Stroke 1993;24:1801-1804.
58. Gordon DL, Bendixen BH, Adams HP Jr, et al. Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke. Neurology 1993;43:1021-1027.
59. Kessler C, Freyberger HJ, Dittmann V, Ringelstein EB. Interrater reliability in the assessment of neurovascular diseases. Cerebrovasc Dis 1991;1:41-43.
60. Rivest J, Quinn N, Marsden CD. Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Neurology 1990;40:1571-1578.
61. Verny M, Jellinger KA, Hauw JJ, Bancher C, Litvan I, Agid Y. Diagnostic criteria for progressive supranuclear palsy (PSP): a retrospective clinicopathological study of 24 cases. Acta Neuropathol 1996;91:427-431.
62. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM. Progressive supranuclear palsy: neuropathologically based diagnostic criteria. J Neurol Neurosurg Psychiatry 1995;58:167-173.
63. Jacobs DH, Adair JC, Macauley BL, Gold M, Gonzalez-Rothi LJ, Heilman KM. Apraxia in corticobasal degeneration (CBD) [abstract]. Neurology 1995;45(suppl 4):A266-A267.
64. Okuda B, Tachibana H. The nature of apraxia in corticobasal degeneration [letter]. J Neurol Neurosurg Psychiatry 1994;57: 1548-1549.
65. Brunt ERP, van Weerden TW, Pruim J, Lakke JWPF. Unique myoclonic pattern in corticobasal degeneration. Mov Disord 1995;10:132-142.
66. Savoiardo M, Girotti F, Strada L, Ciceri E. Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J Neural Transm Suppl 1994;42:93-110.
67. Grisoli M, Fetoni V, Savoiardo M, Girotti F, Bruzzone MG. MRI in corticobasal degeneration. Eur J Neurol 1995;2:547-552.
68. Sawle GV, Brooks DJ, Marsden CD, Frackowiak RS. Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain 1991;114: 541-556.
69. Eidelberg D, Dhawan V, Moeller JR, et al. The metabolic landscape of corticobasal ganglionic degeneration: regional asymmetries studied with positron emission tomography. J Neurol Neurosurg Psychiatry 1991;54:854-862.
70. Blin J, Vidailhet MJ, Pillon B, Dubois B, Febe JR, Agid Y. Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET. Mov Disord 1992;7: 348-354.
71. Brooks DJ. PET studies on the early and differential diagnosis of Parkinson's disease. Neurology 1993;43(suppl 6):S6-S16.
72. Markus HS, Lees AJ, Lennox G, Marsden CD, Costa DC. Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT: comparison with Parkinson's disease and normal controls. Mov Disord 1995;10: 179-187.
73. Vidailhet MJ, Rivaud S, Gouider-Khouja N, et al. Eye movements in parkinsonian syndromes. Ann Neurol 1994;35:420-426.